Our Mission
Advancing Cancer Diagnostics, Improving Lives
Our Vision
From translational research to patient treatment, we envision a world where comprehensive insights enrich cancer diagnosis and offer reassurance to all patients.
News & Events
Leica Biosystems Launches HistoCore CHROMAX Workstation, Advancing its Coverslipping and Staining Portfolio
Leica Biosystems, a global leader in anatomic pathology, is known for its high-quality histology solutions. Today, the company announced the next iteration in its staining and coverslipping portfolio, the HistoCore CHROMAX Workstation (WS).
Leica Biosystems Newcastle Center for Enabling Precision Medicine Achieves CLIA Certification
Leica Biosystems, a global leader in anatomic pathology, has received a Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art research and development facility in Newcastle, United Kingdom.
Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform
Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine paradigm, from early biomarker discovery to clinical trials, and through to routine diagnostics.
Leica Biosystems at a Glance
150+ Years of Innovation
2012 - Present |
New Era of Science & Technology |
2005 - 2011 |
Global Expansion Accelerates |
1989 - 2004 |
Structuring for Comprehensive Workflow |
1930 - 1988 |
Novel Products Drive Company Growth |
1900 - 1930 |
Microtomy Technology Advances Amidst Wartime Realities |
1872 - 1899 |
The Creation of the Microtome and the Early Years of R. Jung GMBH |
About Danaher
Leica Biosystems is proud to be part of Danaher. Danaher’s science and technology leadership puts Leica Biosystems’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.